Level Four Advisory Services’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Level Four Advisory Services’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-55,555	Closed	-$4.98K	–	864
2023 Q3	$4.98K	Buy	+55,555	New	+$5.16K	﹤0.01%	744

Other funds holding NAVB

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

Level Four Advisory Services's NAVB Position: Q4 2023 in Review

Level Four Advisory Services sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2023, closing a stake of 55,555 shares — an estimated $4.98K sold.

Level Four Advisory Services first reported a position in NAVB in Q3 2023 and held it in 1 quarter. The position peaked at $4.98K in Q3 2023. 4 funds tracked by Wall St. Rank hold NAVB as of Q4 2023.

Level Four Advisory Services reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
Level Four Advisory Services sold 55,555 Navidea Biopharmaceuticals Inc. shares in Q4 2023, an estimated $4.98K.
Level Four Advisory Services first reported a position in Navidea Biopharmaceuticals Inc. in Q3 2023 and held it in 1 quarter.
Level Four Advisory Services's Navidea Biopharmaceuticals Inc. position peaked at $4.98K in Q3 2023.
4 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2023.

Based on Level Four Advisory Services's 13F filing for Q4 2023, filed 8 Feb 2024.